Sunday, May 7, 2017

Regulus Therapeutics’ (RGLS) CEO Paul Grint on Q1 2017 Results – Earnings Call Transcript

http://ift.tt/2qkQ6LT

og_image_410-b8960ce31ec84f7f12dba11a09f

May 07, 2017 at 08:46PM

http://ift.tt/2pUUS2L

from

http://ift.tt/2pUUS2L


at

No comments:

Post a Comment